Biofourmis has secured $300m in a series D funding round to support expansion of its virtual care platforms, raising the Boston company’s total funding to $445m.
Minute Insight: Biofourmis Raises $300M To Fund Digital Drug-Companion Therapies
The Boston company will use the new investment to continue scaling its virtual care business. Biofourmis also announced that medtech veteran Omar Ishrak is joining the company’s board as its chairman.
